Search images on Google Product Monograph
Active Ingredients:
- sacituzumab govitecan, 180 MG/VIAL
DIN: 02520788
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FX - (ATC, WHO)
- L01FX17 - SACITUZUMAB GOVITECAN (WHO)
Pharmaceutical standard: MFR